Concepedia

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma

Victor Yazbeck, Danielle Shafer, Edward Brent Perkins, Domenico Coppola, Lubomir Sokol, Kristy L. Richards, Thomas C. Shea, Jia Ruan, Samir Parekh, Roger Strair,

Clinical Lymphoma Myeloma & Leukemia · 2018 · 40 citations · 29 references

DOIFull text

Open access

Concepts

References

29

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine · 2002 · 5.6K citations · Full text

, , +9

Revised Response Criteria for Malignant Lymphoma

Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text

, , +15

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

Andreas Rosenwald, George W. Wright, Wing C. Chan et al. · New England Journal of Medicine · 2002 · 3.9K citations · Full text

, , +16

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

, , +17